Stock DVLA PT DARYA-VARIA LABORATORIA TBK
Add to a list
To use this feature you must be a member
Log inSign up

Company PT Darya-Varia Laboratoria Tbk

Equities

DVLA

ID1000117203

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
1,480 IDR -0.34% Intraday chart for PT Darya-Varia Laboratoria Tbk +1.72% -11.11%
Mar. 22 PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

PT Darya-Varia Laboratoria Tbk is an Indonesia-based pharmaceutical company. Its segments include prescription drugs, consumer health products, export and toll manufacturing services and services. Its consumer health products include skin nutrition, respiratory, vitamins and daily relief. Its prescription products include Daryaven, Urdafalk and Aspilets. Through its multivitamin brands, such as Enervon-C, Enervon Active, Enervon Gold and Supertin, it helps to boost body immune and maintain health. It also provides Imunped as a supplement for kids with Zinc and vitamin C, which are essential for children. Its Forti-D 1000 IU is a health supplement (vitamin) product. Fortagyl provides prevention and treatment of amoebiasis, trichomoniasis, giardiasis and post-operation infections. It provides toll manufacturing services for both local and international principals with its two manufacturing facilities: Gunung Putri and Citeureup manufacturing facilities.

Number of employees: 1,269

Sales per Business

IDR in Million2022Weight2023Weight Delta
Consumer Health Products
50.9 %
1,057,253 55.2 % 961,782 50.9 % -9.03%
Prescription Drugs
37.5 %
638,668 33.3 % 708,418 37.5 % +10.92%
Export & Toll
10.2 %
221,121 11.5 % 193,703 10.2 % -12.40%
Services
1.4 %
- - 26,984 1.4 % -

Sales per region

IDR in Million2022Weight2023Weight Delta
Indonesia
90.8 %
1,714,071 89.4 % 1,717,754 90.8 % +0.21%
International
9.2 %
202,970 10.6 % 173,133 9.2 % -14.70%

Managers

Managers TitleAgeSince
Ian Martin Wibawa Kloer CEO
 Chief Executive Officer 50 20-09-30
Celso Paz Lim DFI
 Director of Finance/CFO 55 22-06-27
Clinton Andrew Hess CHM
 Chairman 53 04-12-31
Bobby Gulliano CTO
 Chief Tech/Sci/R&D Officer - -
Angelito Celso Racho CTO
 Chief Tech/Sci/R&D Officer 62 04-12-31
Sonny Kalona BRD
 Director/Board Member 56 93-12-31
Mariano John Tan BRD
 Director/Board Member 62 05-05-31
Widya Tobing IRO
 Public Communications Contact 48 17-06-07
Deddy Septiadi PRN
 Corporate Officer/Principal - -
Dandan Darmawan HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Clinton Andrew Hess CHM
 Chairman 53 04-12-31
Mariano John Tan BRD
 Director/Board Member 62 05-05-31
Eric Albert Gotuaco BRD
 Director/Board Member 56 19-06-10
Marlia Hayati Goestam CEO
 Chief Executive Officer 63 96-07-31
Sancoyo Antarikso BRD
 Director/Board Member 61 21-09-29
Sonny Kalona BRD
 Director/Board Member 56 93-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,120,000,000 88,199,088 ( 7.875 %) 0 7.875 %

Shareholders

NameEquities%Valuation
United Laboratories, Inc.
92.13 %
1,031,800,912 92.13 % 95 M Rp
Goldman Sachs Advisors BV
0.1717 %
1,923,000 0.1717 % 177 070 Rp

Company contact information

PT Darya-Varia Laboratoria Tbk

South Quarter, Tower C 18th-19th Floor

12430, Jakarta

+

http://www.darya-varia.com
address PT Darya-Varia Laboratoria Tbk(DVLA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
PT DARYA-VARIA LABORATORIA TBK Stock PT Darya-Varia Laboratoria Tbk
-11.11% 102M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.70% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 554B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.72% 349B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.62% 318B
ABBVIE INC. Stock AbbVie Inc.
+7.02% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 210B
NOVARTIS AG Stock Novartis AG
-0.41% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-12.04% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DVLA Stock
  4. Company PT Darya-Varia Laboratoria Tbk